JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level

Natalizumab-treated patients have a higher risk of developing progressive multifocal leukoencephalopathy. Exposure to John Cunningham virus (JCV) is a prerequisite for PML (progressive multifocal leukoencephalopathy). To assess JCV exposure in multiple sclerosis patients, we performed a serological...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lanzillo, Roberta, Liuzzi, Raffaele, Vallefuoco, Luca, Moccia, Marcello, Amato, Luca, Vacca, Giovanni, Vacchiano, Veria, Portella, Giuseppe, Brescia Morra, Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4199559/
https://ncbi.nlm.nih.gov/pubmed/25328396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S63295
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados